In vitro evidence for immune activating effect of specific AGE structures retained in uremia.
about
Immune dysfunction in uremia—an updateManagement of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapyWhat is new in uremic toxicity?Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacyExploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones.The European artificial organ scene: present status.Online hemodiafiltration.The epidemic of cardio-vascular disease in renal failure: where does it come from, where do we go?Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.The intestine and the kidneys: a bad marriage can be hazardous.The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.N-ε-fructosyllysine and N-ε-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion.Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2.
P2860
Q26829076-B070A7EF-CE24-4F85-A728-03EEA3726A66Q26859689-832A6D33-8DB0-4E25-964F-FAE30D41E394Q34589157-68B87D28-E278-4D3D-9EA3-97876634282CQ35113743-90067519-E9E2-4710-8295-9445AD6AFC53Q35891553-10D3B92B-BF69-4304-85B0-F47861BAE6BEQ36097877-4795EF6F-80B7-4823-9A47-2156D71D0724Q36145893-7F3A4C22-93D9-4BE9-A51D-6E9BE145796DQ36566711-A5B80A80-8A97-4527-B7F2-290FA23DEB17Q36714285-8F151686-6468-48B3-85F0-BB78E08C49AAQ37635868-17A1ED37-A4D8-4A61-9633-6B2B1070736AQ38393212-2F9E2FAD-A45B-4566-A576-5FA9983A74CCQ42147370-09092D7D-087D-400E-AEA5-067443876C05Q43595134-2A7F8FED-5EEB-4E6B-917E-65D7C1D2626EQ47208232-1E15FE20-4099-48A4-93B6-9A4CCB614A4C
P2860
In vitro evidence for immune activating effect of specific AGE structures retained in uremia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
In vitro evidence for immune a ...... structures retained in uremia.
@en
In vitro evidence for immune a ...... structures retained in uremia.
@nl
type
label
In vitro evidence for immune a ...... structures retained in uremia.
@en
In vitro evidence for immune a ...... structures retained in uremia.
@nl
prefLabel
In vitro evidence for immune a ...... structures retained in uremia.
@en
In vitro evidence for immune a ...... structures retained in uremia.
@nl
P2093
P1433
P1476
In vitro evidence for immune a ...... structures retained in uremia.
@en
P2093
Griet Glorieux
Norbert Lameire
Philippe Brunet
Reinhold Deppisch
Ruediger Helling
P304
P356
10.1111/J.1523-1755.2004.00961.X
P407
P577
2004-11-01T00:00:00Z
P5875
P6179
1011783451